About BiossancePioneering sustainable beauty through biotechnology, at Biossance we created a 100% plant-based squalane skincare line that is delivering the leading skin moisturizer while using only safe and sustainable ingredients. We formulate with a No Compromise™ approach, proudly blacklisting over 2,000 potentially harmful ingredients because the products you use make a difference for your health and the health of the planet. Biossance makes sure only the most trustworthy and powerful ingredients make the final cut. Because we believe and are committed to delivering both best performing and clean beauty products. The full Biossance skin care line can be found at www.Biossance.com and www.SEPHORA.com.About AmyrisAmyris is the integrated renewable products company that is enabling the world's leading brands to achieve sustainable growth. Amyris applies its innovative bioscience solutions to convert plant sugars into hydrocarbon molecules and produce specialty ingredients and consumer products. The company is delivering its No Compromise® products across a number of markets, including specialty and performance chemicals, flavors and fragrances, cosmetics ingredients, pharmaceuticals, and nutraceuticals. More information about the company is available at www.amyris.com. Forward-Looking StatementsThis release contains forward-looking statements, and any statements other than statements of historical facts could be deemed to be forward-looking statements. These forward-looking statements include, among other things, statements regarding future events (such as expected expansion of Biossance in SEPHORA Canada locations and other international locations and anticipated Biossance sales results and consumer demand) that involve risks and uncertainties. These statements are based on management's current expectations and actual results and future events may differ materially due to risks and uncertainties, including risks related to manufacturing capacity at Amyris's Brotas facility, delays or failures in development, production and commercialization of products, liquidity and ability to fund capital expenditures, Amyris's reliance on third parties to achieve its goals, and other risks detailed in the "Risk Factors" section of Amyris's quarterly report on Form 10-Q filed on May 15, 2017. Amyris disclaims any obligation to update information contained in these forward-looking statements whether as a result of new information, future events, or otherwise. Amyris, the Amyris logo, and Biossance, and No Compromise are registered trademarks of Amyris, Inc. All other trademarks are the property of their respective owners.
ContactsElle Communications Media Contact: Megan Heybiossance@ellecomm.com+1 (855) 438-3553Peter DeNardoDirector, Investor Relations and Corporate CommunicationsAmyris, Inc. +1 (510) firstname.lastname@example.org@amyris.com